TBCK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.518200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.524200E-01
Normal-vs-Stage2
3.278800E-01
Normal-vs-Stage3
7.352300E-02
Normal-vs-Stage4
5.414800E-01
Stage1-vs-Stage2
9.378400E-01
Stage1-vs-Stage3
9.314100E-02
Stage1-vs-Stage4
2.871800E-01
Stage2-vs-Stage3
2.098000E-01
Stage2-vs-Stage4
2.726000E-01
Stage3-vs-Stage4
1.116960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.408800E-01
Normal-vs-AfricanAmerican
5.584200E-01
Normal-vs-Asian
3.435000E-01
Caucasian-vs-AfricanAmerican
7.524200E-01
Caucasian-vs-Asian
5.573000E-01
AfricanAmerican-vs-Asian
5.968400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.587200E-01
Normal-vs-Female
4.899600E-01
Male-vs-Female
1.809780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.578800E-01
Normal-vs-Age(41-60Yrs)
7.063600E-01
Normal-vs-Age(61-80Yrs)
2.309400E-01
Normal-vs-Age(81-100Yrs)
1.123410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.909000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.488200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.286800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.779500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.018990E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.082600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.902000E-01
Normal-vs-Daily Drinker
1.243840E-01
Normal-vs-Weekly Drinker
1.529030E-01
Normal-vs-Occasional Drinker
6.787600E-01
Normal-vs-Social Drinker
6.753200E-01
Non Drinker-vs-Daily Drinker
3.659000E-01
Non Drinker-vs-Weekly Drinker
6.526000E-01
Non Drinker-vs-Occasional Drinker
1.899770E-01
Non Drinker-vs-Social Drinker
1.787970E-01
Daily Drinker-vs-Weekly Drinker
7.201200E-01
Daily Drinker-vs-Occasional Drinker
3.821500E-02
Daily Drinker-vs-Social Drinker
3.363600E-02
Weekly Drinker-vs-Occasional Drinker
1.098560E-01
Weekly Drinker-vs-Social Drinker
8.788300E-02
Occasional Drinker-vs-Social Drinker
9.492200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.436200E-02
Normal-vs-Grade 2
4.883600E-03
Normal-vs-Grade 3
1.731680E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.455810E-01
Grade 1-vs-Grade 3
6.161700E-02
Grade 1-vs-Grade 4
5.436200E-02
Grade 2-vs-Grade 3
2.827800E-01
Grade 2-vs-Grade 4
4.883600E-03
Grade 3-vs-Grade 4
1.731680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.088400E-01
Normal-vs-NonDiabetic
3.002000E-01
Diabetic-vs-NonDiabetic
4.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.856400E-01
Normal-vs-NoPancreatitis
2.886600E-01
Pancreatitis-vs-NoPancreatitis
8.333400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.395600E-01
Normal-vs-N1
3.483000E-01
N0-vs-N1
9.343400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.143400E-01
Normal-vs-TP53-NonMutant
3.641200E-01
TP53-Mutant-vs-TP53-NonMutant
4.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
